Xeljanz 56 tablets 5mg

Description

Xeljanz (generic name: tofacitinib) is a Janus Kinase inhibitor (JAKi) used to treat immune-mediated diseases (IMDs) such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis or ankylosing spondylitis in adults.

It can also be prescribed off-label to treat psoriasis and hair loss caused by alopecia areata as well as conditions that have not responded well to alternative treatment, including rheumatic diseases like dermatomyositis, polymyositis, systemic sclerosis, systemic lupus erythematosus.

When treating various forms of arthritis, it aims to decrease the pain, tenderness, and swelling in affected joints. For ulcerative colitis, it reduces symptoms such as stomach pain, diarrhea, and rectal bleeding.

Dosage

The usual procedure is to take the medicine orally with or without food. Follow the instructions from your prescribing healthcare provider and the guidelines printed on the patient instruction leaflet included in the package.

Storage

Store this medication away from the reach of infants and children, in temperatures below 25°C / 77°F. The shelf life after first opening the packs of 28 and 60 tablets is 30 days, after which any unused tablets should be disposed of. Please read our friendly tips on handling medicine safely.